United States · FDA National Drug Code directory
Venlafaxine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-003_1eee52e9-dda9-0d36-e063-6394a90a905b
- Product NDC
- 31722-003
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Venlafaxine Hydrochloride
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190708
- Source listing expiry
- 20261231
Source-listed ingredients
- VENLAFAXINE HYDROCHLORIDE — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 CARTON (31722-003-01) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK · 31722-003-01
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (31722-003-05) · 31722-003-05
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (31722-003-30) · 31722-003-30
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (31722-003-90) · 31722-003-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →